REG - East Imperial PLC - Requisition of Extraordinary General Meeting

East ImperialAnnouncement

17/11/2021 07:05

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211117:nRSQ6554Sa&default-theme=true

RNS Number : 6554S  East Imperial PLC  17 November 2021

17 November 2021

 

 East Imperial plc

("East Imperial" or the "Company")

 

Requisition of Extraordinary General Meeting

 

East Imperial, the global purveyor of ultra-premium beverages, announces that
it has received a letter from Taylor Partners Limited requisitioning an
extraordinary general meeting of the Company's shareholders (the
"Requisition"), requiring the Company to convene an extraordinary general
meeting within 21 days from the date of receipt by the Company of the
Requisition. This was accompanied by a letter from Dr Andrew Regan, Chief
Executive of Corvus Capital Limited, as an adviser to Taylor Partners Limited.
The meeting must be held within 28 days from the date the meeting is convened.

 

The Requisition proposes resolutions that the Chairman of the Company, Rob
Soni, and Dr Olufunke Abimbola be removed from office as directors of the
Company and that Alistair McGeorge be appointed as a non-executive director of
the Company and the non-executive chairman of the Company and Colin Henry be
appointed as a non-executive director of the Company, all with immediate
effect.

 

The Board is disappointed that Dr Regan thought it necessary to seek a
Requisition, with the Board having already noted in its announcement of 29
September 2021 that it may be beneficial to add additional Boardroom
experience. Since then, the Board has commenced a formal process to appoint
additional non-executives with an emphasis on increasing the level of UK PLC
boardroom experience and premium beverage expertise.

 

As part of this process, the Board reviewed the CVs of the proposed new
directors and has interviewed one of them. Following that exercise, the Board
reiterates its view that both Dr Regan's chosen candidates appear to have
little or no recent PLC experience or expertise in the premium beverage
sector.

 

Dr Regan's Requisition is a further step in his continuing attempts to
undermine the Board and the significant operational progress that has been
achieved by the Company since its listing in July. The Board is firmly of the
view that Dr Regan's proposals and his actions to date are a blatant attempt
to insert his own representatives on to the Board in order to gain control of
the Company without paying a premium to all shareholders.

 

The Board of Directors' detailed response to the Requisition will be announced
in due course in accordance with the requirements of the Companies Act 2006.
In the meantime, shareholders are advised to take no action at this time.

 

The information contained within this announcement is deemed by the Company to
constitute inside information for the purposes of the Market Abuse Regulation
(EU) No. 596/2014 as it forms part of UK domestic law by virtue of the
European Union (Withdrawal) Act 2018.  Upon the publication of this
announcement via the Regulatory Information Service, this inside information
is now considered to be in the public domain.

 

Ends

 

 

 

Enquiries:

 

MHP Communications

Peter Hewer    +44 (0) 770 9326 261

Rachel Mann +44 (0) 758 5301 464

eastimperial@mhpc.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCUBSNRAUUAARA